BCLS Fund III Investments, LP
Follow13F filer, CIK 1952107, Boston, MA
BCLS Fund III Investments, LP filed a 13F-NT notice for the quarter ended 2025-03-31 on 2025-05-15.
Filed (acceptance time not in the bulk data set), ingested 13F-NT 0000950123-25-005449
This filer reports no holdings of its own for Q1 2025. It filed a 13F-NT notice, and its holdings are in the report of
- Bain Capital Life Sciences Investors, LLC
- Bain Capital Life Sciences III General Partner, LLC
- Bain Capital Life Sciences Fund III, L.P.
- BCLS Fund III Investments GP, LLC
Changes against Q4 2024 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.
Stakes and trades reported after 2025-03-31
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- ADRX ADARX PHARMACEUTICALS INC: 13G 6,728,970 shares, 6.3% of the class, 13G filed 2026-10-01, 0001193125-26-410626Timeline
Accepted , ingested
How Q1 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-NT 0000950123-25-005449 | notice | 2025-05-15 | acceptance time not in the bulk data set |